TUESDAY, Jan. 14, 2025 (HealthDay News) — A popular diabetes drug can provide protection against skin cancers, a new study says.
2025
Study identifies best imaging methods for evaluating brain tumor response in melanoma patients
Raymond Y. Huang, MD, Ph.D., of the Department of Radiology at Brigham and Women’s Hospital, is the corresponding author of a paper published in the Journal of Clinical Oncology, “Comparative Analysis of Intracranial Response Assessment Criteria in Patients With Melanoma Brain Metastases Treated With Combination Nivolumab + Ipilimumab in CheckMate 204."
Effect of Sex on Melanoma Survival Due to Clinicopathological Features
WEDNESDAY, Jan. 15, 2025 (HealthDay News) — The female survival advantage seen in melanoma is mainly a result of an indirect effect of sex mediated by clinicopathological features, according to a study published online Jan. 12 in JNCI Cancer Spectrum.
Penn Medicine scientists develop tiny anticancer weapon
PHILADELPHIA – A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study from researchers in the Perelman School of Medicine at the University of Pennsylvania.